Company Financials

DaShenLin Pharmaceutical Group Co. Ltd Financials

Renminbi

business DaShenLin Pharmaceutical Group Co. Ltd Company Profile

Main Stock Listing

SSE: 603233

Market Capitalization CN¥15.80 Billion as of Jan. 1, 2025

Market Cap History

Valuations Metrics as of Jan. 25, 2025

Trailing PE 18.49
Forward PE 11.28
Price to Sales TTM CN¥0.60
Price to Book MRQ CN¥2.30
Enterprise to Revenue 0.70
Enterprise to EBITDA 11.55

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends 2023-12-31
Most Recent Quarter 2024-09-30
Profit Margin 3.20%
Operating Margin 5.35%
Return on Assets TTM 3.64%
Return on Equity TTM 11.53%

Income Statement

Revenue TTM CN¥26,539,247,616
Revenue per Share TTM CN¥23.37
Quarterly Revenue Growth 11.40%
Gross Profit TTM CN¥9,010,933,760
EBITDA CN¥3,240,705,972
Net Income to Common TTM CN¥850,262,784
Diluted EPS TTM CN¥0.75
Quarterly Earnings Growth YoY -22.00%

Balance Sheet

Total Cash MRQ CN¥5,724,121,600
Total Cash per Share MRQ CN¥5.03
Total Debt MRQ CN¥
Total Debt to Equity MRQ 90.14
Current Ratio MRQ 0.92
Book Value per Share MRQ CN¥6.03

Cash Flow

Operating Cash Flow TTM CN¥3,201,892,864
Levered Free Cash Flow TTM CN¥2,995,444,224

603233 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding 1,138,850,048
Float Shares 403,755,737
Avg 10 Volume 5,802,080
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 66.51%
% Held by Institutions 7.63%

Stock Price Summary

Beta 0.34
Fifty Two Week Low CN¥11.92
Fifty Two Week High CN¥27.10
Fifty Two Week Change -72.39%
Day 50 MA CN¥15.23
Day 200 MA CN¥16.07

Dividends and Splits

Forward Annual Dividend Rate CN¥1.24
Forward Annual Dividend Yield 8.94%
Trailing Annual Dividend Rate CN¥0.31
Trailing Annual Dividend Yield 2.24%
Payout Ratio 41.33%
Dividend Date
Ex Dividend Date 2024-10-23
Last Split Factor
Last Split Date 2023-06-09